Adverum Biotechnologies' IPO

Adverum Biotechnologies raised a round of funding on July 31, 2014. Investors include Public.

Adverum Biotechnologies, formerly Avalanche Biotechnologies, is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases.…

Articles about Adverum Biotechnologies' IPO: